JAK2 and myeloproliferative disorder: Very recently, the JAK2 V617F mutation was detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms [24], thus suggesting that, although rare, this JAK2-activating mutation may occur also in B-CLL.